Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.
about
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deletedInhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferonsA derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cellsStrain-specific neutralization of human cytomegalovirus isolates by human sera.Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismIdentification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challengeIdentification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesvirusesComparison of antiviral activities of cloned and native human interferons against herpes simplex virus types 1 and 2 and human cytomegalovirus.Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placentaGlycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infectionCharacterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodiesThe dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specificCell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody responseIdentification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.Identification and expression of a human cytomegalovirus early glycoprotein.Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetrationHuman cytomegalovirus binding to fibroblasts is receptor mediated.A multigene family encodes the human cytomegalovirus glycoprotein complex gcII (gp47-52 complex).Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirusViral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirusThe human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex.Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro.Characterization of membrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies.Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system.Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.Human immune responses to major human cytomegalovirus glycoprotein complexes.Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein.Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.
P2860
Q24655638-77FCCA65-4DF1-4A02-9D75-4EA5CE4895E3Q28365700-D9E849EE-EC41-4D09-A7F4-69DBB6E68513Q33558900-F48E75A0-DBD1-4D7D-BD2B-3510805C371DQ33640031-9B3EC72F-BC58-4169-BBB3-5950DC7C5A3EQ33646932-61F24CB4-4ABE-4BDB-9722-C01D23FB7510Q34212879-69D64558-7EED-4C97-A190-F3BE0CFF3DA4Q34326797-C9EE9B26-E638-4BEA-A0E9-20D27466AB20Q34970937-33C5D321-3492-44B2-A098-981A1519C702Q35495255-FEC2EFDD-16CB-4222-9834-2C5544A649AEQ35640231-FA438F2B-E84D-40DF-8A50-57620E648926Q35850918-0B092F7D-E9A8-4E61-B2B1-F9FB7A8EA613Q35857373-792622E7-4538-4530-B329-63D58551F9CEQ35881192-818E12E8-BED7-4F89-B2A9-76124FF29FA6Q35887796-F44A8DA0-79E9-4FDB-B290-199C4CDF6E87Q35888421-EC20CAF4-0023-4AB9-B148-FA68A65CD1EEQ36640069-0752141A-348B-43AE-B5F4-B988BFB3C1CCQ36640712-2B83F9FA-B0A4-4B12-8458-C3199EC0B2D5Q36691252-2EC86ECD-AAED-47F9-9FBF-71406EB68BC2Q36802016-855A99B8-0978-4D8C-AC78-5FC9BE9AB0A5Q36827278-9DCB71FF-44EC-4A3E-A065-A71A1E3BB278Q36829799-F225519B-EB36-4F82-838E-1CCA0C01B088Q36829924-C2E31B63-318B-4752-80EF-A17179D2D24AQ36830676-59B8D75D-143D-4CBD-8B22-1D5E8CEC0631Q36868657-8025AAA3-2E8A-4F18-9D6B-FB5DDFD4E36CQ36872453-F7284660-F56C-41A9-8554-FC21CDF6173CQ36876105-866F926D-FAE1-42E6-97A1-2C4DC4BC5F99Q36903073-7899B6D3-D891-4DDA-81E0-A2439D676A07Q39581316-4403C61F-25CA-4809-B92A-1400A993D04EQ39682836-88CAC440-E366-471A-977D-2DF2464EBAE1Q39685388-BF5E26CB-2A02-4C53-B864-060FA5384308Q40060796-E8885EBD-CDAD-40A0-9338-420DD595671DQ40100984-96EFD23D-62CE-4CB3-B943-F6597193A0F4Q40106911-1E31017B-AB64-4ACD-8E04-9B4902A80E7BQ40117416-E1CACF8A-9348-4D07-AC79-6F0D9FC1DB4FQ40127535-E8C39AD1-8793-42EF-B640-E0A1C2A19A7AQ40130017-CADC65BD-5BE5-4903-8EAA-20CBC0A081FEQ40191687-053E647F-66D5-428F-8F63-CC65965CB865Q40308093-28A9FBA5-1C57-478F-AC1B-B7A448521274Q40416401-F51386D0-126D-4F7B-8718-915543BE85C0Q40883283-4476BF59-3836-495B-8A10-FA8359DAA67B
P2860
Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@ast
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@en
type
label
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@ast
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@en
prefLabel
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@ast
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@en
P2093
P2860
P356
P1476
Murine monoclonal antibody to ...... vity of human cytomegalovirus.
@en
P2093
D C Kelsall
L E Rasmussen
R M Nelson
T C Merigan
P2860
P304
P356
10.1073/PNAS.81.3.876
P407
P577
1984-02-01T00:00:00Z